
News|Articles|February 1, 2003
Serious respiratory adverse events may be associated with salmeterol in patients with asthma
Glaxo-SmithKline (GSK) has advised prescribers of salmeterol (Serevent) about rare, but potentially serious, respiratory adverse events in patients with asthma.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Eric Levine, M.P.H., on Medicaid work requirement exemptions and ADLs
2
New cholesterol guideline expands treatment eligibility to 55% of U.S. adults
3
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1
4
Acute pain drug Journavx helps drive Vertex growth in second quarter
5
























